Suppliers / Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

Japan Updated 9 July 2026

The public registers hold a second record for Takeda Pharmaceutical Company Limited. The fuller profile, with 0 active US DMFs and 0 valid CEPs, is at Takeda Pharmaceutical. Figures on this page cover only this record.

Takeda Pharmaceutical Company Limited is a finished-dose manufacturer based in Japan.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Dexlansoprazole SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Dexlansoprazole finished dose

Questions about Takeda Pharmaceutical Company Limited

What does Takeda Pharmaceutical Company Limited make?
1 molecule is on record against Takeda Pharmaceutical Company Limited, including Dexlansoprazole. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Takeda Pharmaceutical Company Limited comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Bushu Pharmaceuticals also in Japan Chugai Pharma Manufacturing also in Japan Eisai also in Japan Hisamitsu Pharmaceutical also in Japan Kyowa Kirin also in Japan

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability